Value Aligned Research Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRWV
CoreWeave
CRWV
|
+$364M |
| 2 |
EQT Corp
EQT
|
+$100M |
| 3 |
NRG Energy
NRG
|
+$83.5M |
| 4 |
Constellation Energy
CEG
|
+$73.9M |
| 5 |
Broadcom
AVGO
|
+$67.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$200M |
| 2 |
Micron Technology
MU
|
+$51.7M |
| 3 |
Fabrinet
FN
|
+$25.3M |
| 4 |
Core Scientific
CORZ
|
+$23M |
| 5 |
NBIS
Nebius Group N.V.
NBIS
|
+$15.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.17% |
| 2 | Utilities | 11.81% |
| 3 | Industrials | 10.02% |
| 4 | Financials | 4.5% |
| 5 | Communication Services | 2.8% |
Similar funds
Value Aligned Research Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Value Aligned Research Advisors held 83 positions worth $8.19B, up 73% from $4.73B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Value Aligned Research Advisors deployed $1.73B of net new capital in Q3 2025, opening 11 new positions and adding to 38 existing holdings. Its largest new stake was CoreWeave: 3,079,120 shares worth $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Utilities and Industrials.
On the sell side, the largest reduction was GE Vernova, an estimated $200M trimmed.
- Value Aligned Research Advisors's largest Q3 2025 buy was CoreWeave: 3,079,120 shares worth $421M.
- Value Aligned Research Advisors added most to EQT Corp in Q3 2025, an estimated $100M increase.
- Value Aligned Research Advisors's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $200M.
- Value Aligned Research Advisors fully exited Core Scientific in Q3 2025, selling an estimated $23M.
- Value Aligned Research Advisors's ten largest holdings make up 46% of its $8.19B portfolio in Q3 2025.
- Value Aligned Research Advisors opened 11 new positions and closed 2 in Q3 2025.
- Value Aligned Research Advisors's portfolio value rose 73% quarter-over-quarter to $8.19B.
Based on Value Aligned Research Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.